|
KMID : 0370220200640040265
|
|
Yakhak Hoeji
2020 Volume.64 No. 4 p.265 ~ p.272
|
|
|
Analysis on the Consumer Behavior and Perception of Similar Nomenclature of Series named Nonprescription drugs
|
|
Kim Jeong-Eun
Lim Sung-Cil
|
|
|
Abstract
|
|
|
|
Medication error might be prevented and one of medication error is name-confusion error. Especially OTC(Over-the-counter medicine) drug can be often used as self-treatment by patient and recognition of exact drug name foreach indication is very important. However, many of the series named OTC products exist currently on the market, andit may act as a barrier for proper use of OTC products for customers. The “series named over-the-counter medicine” refersto a product name that adds letters, words or numbers to an already existing OTC brand name. There are many ‘Seriesnamed Over-the-counter medicine’ in Korean pharmaceutical market for promotional purposes by the pharmaceuticalcompanies. The Series named OTC products may have advantages in terms of product management, but they also carrythe risk that they may confuse pharmacists and consumers due to similar names. Therefore we evaluated the knowledgeand use behavior of Series named OTC medicine, from December 5 to 18, 2019 by an online survey for general public. The results showed that 12 brands of the top 20 OTC products in sales owned the Series named product, and 87.1% of186 customers said that they don’t know the difference between series product. And ‘pharmacist’s recommendation’(58.6%) was the most essential factor in selecting the OTC product. In conclusion, most consumers are not aware of thetherapeutic differences between the Series named OTC products in each one brand. The benefit and safety issues of Seriesnamed product nomenclature must be evaluated before the marketing for preventing drug name confusion.
|
|
|
KEYWORD
|
|
|
OTC (Over-the-counter) medicine, Series name, Safety, Confusion, Indication
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|